Immunometabolic signatures predict risk of progression to sepsis in COVID-19. Herrera-Van Oostdam AS, Castaneda-Delgado JE, Oropeza-Valdez JJ, Borrego JC, et al. PLoS One 2021;16:e0256784.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Herrera-Van Oostdam AS, Castaneda-Delgado JE, Oropeza-Valdez JJ, Borrego JC, et al. Immunometabolic signatures predict risk of progression to sepsis in COVID-19. PLoS One 2021;16:e0256784.
PMID: 34460840